BACIL PHARMA LTD. Share Price

BACIL PHARMA LTD. Share Price

BSE: 524516
|
Pharmaceuticals
|
S Cap
₹ 13.81
-₹0.72 (-4.96%)
1D
Last updated 13 Aug, 2026, 14:13 IST

BACIL PHARMA LTD. Share Price Today

As of 14 Aug 2026, BACIL PHARMA LTD. share price is ₹13.81. The stock opened at ₹13.81, compared to its previous close of ₹14.53. During today's trading session, BACIL PHARMA LTD. share price moved in the range of ₹13.81 to ₹13.81, with an average price of ₹13.81 for the day. Looking at its last 52-week, the stock has touched a low of ₹13.81 and a high of ₹61.80.

₹13.81
4.96% down today
₹13.81
1D LOW
1D HIGH

BACIL PHARMA LTD. Returns Calculator

Circuit
L
H
₹13.81
₹15.25
52-week
L
H
₹13.81
₹61.80

About BACIL PHARMA LTD.

BACIL PHARMA LTD. Share Price
ISIN
INE711D01018
Sector Market Cap
₹ 19.82 Cr

Bacil Pharma Limited is an India-based pharmaceutical company, which is engaged in the business of manufacturing of pharmaceuticals, medicinal chemicals and botanical products. The Company operates as a manufacturer, exporter, supplier and retailer of a range of anti-anxiety medicine, antihistamines, chemical compound, drugs, and herbal tablets and capsules.

BACIL PHARMA LTD. Financial Highlights

  • Revenue: BACIL PHARMA LTD. reported revenue of ₹1.24 crore in FY26 vs ₹0.66 crore in FY25. It showed an increase of 87.88% on a yearly basis.
  • Operating Profit: BACIL PHARMA LTD. reported an operating profit of ₹0.99 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 141.46% on a year-on-year basis.
  • Net Profit: BACIL PHARMA LTD. reported a net profit of ₹1.56 crore in FY26 vs ₹0.40 crore in FY25. It showed an increase of 290.00% on a yearly basis.

BACIL PHARMA LTD. Quarterly Result Highlights

  • BACIL PHARMA LTD. reported revenue of ₹0.11 crore in Mar 2026, compared with ₹0.06 crore in Dec 2025, representing an increase of 83.33% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported an operating profit of ₹0.04 crore in Mar 2026, compared with ₹0.04 crore in Dec 2025, representing an increase of 0.00% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported a profit of ₹0.62 crore in Mar 2026, compared with ₹0.04 crore in Dec 2025, reflecting an increase of 1,450.00% on a QoQ basis.
  • The earnings per share (EPS) of BACIL PHARMA LTD. stood at ₹0.64 during Mar 2026.
Know more
Promoters
0.00%
FII
0.00%
Other DII
0.00%
Retail and other
100.00%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
19.82
P/E
12.79
P/B
0.79
ROE
6.27%
D/E
0.00
ROCE
3.99%
Div. Yield
0.00%
EPS(TTM)
1.11
Turnover
0.00
EV/EBITDA
119.30
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.37%
Quick Ratio
0.00
Curr. Ratio
0.68
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bacil Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bacil Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.654.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

BACIL PHARMA LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.66₹0.13₹0.11₹0.06
Total Revenue₹0.66₹0.13₹0.11₹0.06
Total Expenses₹0.25₹0.19₹0.22₹3.92
Profit Before Tax₹0.41-₹0.06-₹0.10-₹3.86
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹0.40-₹0.06-₹0.10-₹3.86
EPS - Basic₹0.64-₹0.10-₹0.17-₹6.55
EPS - Diluted₹0.64-₹0.10-₹0.17-₹6.55

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.41-₹0.06-₹0.10-₹3.86
Income before WC changes₹0.38-₹0.09-₹0.13-₹3.91
Change in Assets-₹0.04₹0.00₹0.00₹0.05
Change in Liabilities₹0.06₹0.09-₹0.02-₹0.15
Change in WC₹0.02₹0.08-₹0.02-₹0.10
Cash flow from Operations₹0.40₹0.00-₹0.15-₹4.01
Cash flow from Investing₹0.34₹0.08-₹0.12₹3.81
Cash flow from Financing₹2.08-₹0.06₹0.06₹0.33
Total Cash Flow₹2.82₹0.01-₹0.20₹0.13
Cash (Start of the year)₹0.04₹0.03₹0.23₹0.10
Cash (End of the year)₹2.86₹0.04₹0.03₹0.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹22.69₹1.27₹0.90₹0.96
Current Assets₹2.91₹0.05₹0.23₹0.32
Total Assets₹25.60₹1.33₹1.13₹1.27
Current Liabilities₹0.17₹0.11₹0.03₹0.05
Net Current Asset₹2.74-₹0.06₹0.20₹0.27
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹25.43₹1.21₹1.10₹1.22
Total Equity & Liabilities₹25.60₹1.33₹1.13₹1.27
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
13.81
495074
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 495074
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
1
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
6.66
Bearish
ATR (14)
1.08
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
79.5
Bearish
UO(9)
2.9
Bullish
ROC(12)
-45.76
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
16.13
16.23
10D
18.47
18.74
20D
24.56
23.47
50D
35.01
32.59
100D
44.54
38.67
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
BACIL PHARMA LTD. Share Price
BACIL PHARMA LTD.
Pharmaceuticals
Add Stock
Add Another

BACIL PHARMA LTD. Share Price FAQs